Are Patients With Chronic Inflammatory Disease at Risk for Early Menopause?

Article

Lead researcher Dr Janet McLaren discusses the results of a new study exploring new concerns that rheumatoid arthritis, lupus, and inflammatory bowel disease may lead to premature ovarian failure and early menopause.

Chronic inflammatory diseases such as rheumatoid arthritis, lupus, and inflammatory bowel disease, negatively affect patients’ physical and psychological health. In fact, these diseases have been associated with gynecological complications, including menstrual and pelvic abnormalities, which can further negatively impact quality of life. Now, there are new concerns that these diseases may lead to premature ovarian failure and early menopause.

We invited lead researcher Dr Janet McLaren to discuss the results of this new study, which was presented at the 67th Annual Meeting of the American Society for Reproductive Medicine. Dr McLaren is an assistant professor in the division of reproductive endocrinology and infertility at the University of Alabama at Birmingham. 

Are Patients With Chronic Inflammatory Disease at Risk for Early Menopause?

Reference:
McLaren JF, Haynes K, Barnhart KT, et al. Early menopause in women with chronic inflammatory disease: a population-based cohort study. Presented at the 67th Annual Meeting of the American Society for Reproductive Medicine. Oct. 17, 2011; Orlando.

Related Videos
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit: rmanetwork.com
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit: uvahealth.com.
Hot flashes poorly impact sleep quality | Image Credit: intimmedicine.com
How to manage bone health in midlife women | Image Credit: - endocrine.org
Mary Jane Minkin, MD, discusses The Menopause Society 2023 Annual Meeting | Image Credit: Yale School of Medicine
Highlights from The Menopause Society 2023 Annual Meeting  | Image Credit: nursebarb.com
How fezolinetant changes management of hot flashes | Image Credit: medschool.cuanschutz.edu.
Fezolinetant effective against vasomotor symptoms | Image Credit: med.unc.edu
Gloria Richard-Davis MD, MBA, NCMP, FACOG
Related Content
© 2024 MJH Life Sciences

All rights reserved.